Teva

Global Generic Pharmaceuticals Company.

Launch date

1901

Employees

Market cap

Net debt

($16.9b)

Enterprise valuation

$35.7b (Public information from Jun 2024)

Petah Tikva Center District (HQ)

http://www.tevapharm.com

https://twitter.com/tevapharm https://www.facebook.com/tevapharm https://www.linkedin.com/company/teva-pharmaceuticals/

View job openings

Deals in current and previous year:

Revenues, earnings & profits over time

USD	2019	2020	2021	2022	2023	2024	2025
Revenues	0000	0000	0000	0000	0000	0000	0000
% growth	(8 %)	(1 %)	(5 %)	(6 %)	6 %	-	3 %
EBITDA	0000	0000	0000	0000	0000	0000	0000
% EBITDA margin	19 %	28 %	29 %	28 %	27 %	-	-
Profit	0000	0000	0000	0000	0000	0000	0000
% profit margin	(6 %)	(24 %)	3 %	(16 %)	(4 %)	-	-
EV / revenue	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
EV / EBITDA	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
R&D budget	0000	0000	0000	0000	0000	0000	0000
R&D % of revenue	6 %	6 %	6 %	6 %	6 %	-	-

Get premium to view all results

Date	Investors	Amount	Round
-	investor	$0.0	round
Feb 1982	N/A	$0.0	round
Feb 2010	N/A	$0.0	round
Feb 2018	investor	$0.0	round
Dec 2023*	Affinity Asset Advisors	$12.0m	Post IPO Equity
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.

exited

exited

ACQUISITION by Roche Dec 2017

ACQUISITION by Teva Jul 2015

Cocrystal Discovery

ACQUISITION by Biozone Pharmaceuticals Jan 2014

ACQUISITION by Teva May 2011

Heptares Therapeutics

ACQUISITION by Sosei Group Feb 2015

Auspex Pharmaceuticals

ACQUISITION by Teva Mar 2015

exited